Kiniksa Pharmaceuticals
Price & Volume
Stats
See more52W Range | $18.25-$49.12 |
Market Cap | $3.3B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $677.5M |
Revenue Growth (YoY) | 65% |
Gross Profit (12 Mos) | $370.3M |
Diluted EPS | $0.45 |
News
See moreYahoo Finance • 2 days ago
Kiniksa price target raised to $53 from $50 at Wedbush
Yahoo Finance • 9 days ago
Shopify, eBay upgraded: Wall Street's top analyst calls
Yahoo Finance • 2 months ago
Exploring High Growth Tech Stocks In The US December 2025
Yahoo Finance • 2 months ago
Why Analysts Favor Kiniksa Pharmaceuticals (KNSA)
About
CEO | Mr. Sanj K. Patel |
CFO | Mr. Mark A. Ragosa C.F.A. |
Address | 105 Piccadilly, London, United Kingdom, W1J 7NJ |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 315 |
